Arnoldas Giedrimas, MD
Clinical Cardiac Electrophysiology · Providence, RINPI 1073799573
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 65.4% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $4,372, 4.5 times the $966 reported in 2019.
Across 45 payments — averaging $160.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$1K
- Philips North America LLC$945
- Boston Scientific$71
- Biotronik Inc.$62
- Cardiva Medical, Inc.$51
- plus $42 from 2 others
Across 44 payments — averaging $2162.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$92K
- Medtronic$3K
What the payments were for
- Consulting fees$90012%
- Speaking & faculty fees$1,75024%
- Travel & lodging$3,25145%
- Food & beverage$1,31718%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 27 | $4,728 |
| Abbott | 10 | $1,334 |
| Philips North America LLC | 2 | $945 |
| Boston Scientific | 1 | $71 |
| Biotronik Inc. | 1 | $62 |
| Cardiva Medical, Inc. | 2 | $51 |
| Shockwave Medical, Inc | 1 | $22 |
| Cordis US CORP. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical cardiac electrophysiology providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 200 | $189,548 |
| XareltoRivaroxaban | 111 | $93,826 |
| Dofetilide | 75 | $23,876 |
| MultaqDronedarone Hcl | 12 | $22,871 |
| Metoprolol Succinate | 258 | $4,046 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 83 | $2,029 |
| SotalolSotalol Hcl | 67 | $1,910 |
| Amiodarone Hcl | 83 | $1,658 |
| Flecainide Acetate | 32 | $1,026 |
| Nadolol | 23 | $723 |
| Carvedilol | 16 | $430 |
| Losartan Potassium | 27 | $426 |
| Furosemide | 52 | $409 |
| Lisinopril | 33 | $294 |
| Warfarin Sodium | 23 | $278 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Providence
- Daniel PhilbinProvidence$15K
- David ShimProvidence$14K
- Xiaoxiao QianProvidence$13K
- Carlos CuelloProvidence$7K
- Jerome KalifaProvidence$6K
- Rupa BalaProvidence$1K
- Michael WuEast Providence$18K
- Malcolm KirkWoonsocket$11K
- John RodriguezLincoln$9K
- Estelle TorbeyEast Providence$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.